These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38664148)

  • 1. Alzheimer's disease prevention: Apolipoprotein e4 moderates the effect of physical activity on brain beta-amyloid deposition in healthy older adults.
    Pedrero-Chamizo R; Zhuang K; Juarez A; Janabi M; Jagust WJ; Landau SM
    J Sci Med Sport; 2024 Jun; 27(6):402-407. PubMed ID: 38664148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain Oxygen Extraction by Using MRI in Older Individuals: Relationship to Apolipoprotein E Genotype and Amyloid Burden.
    Lin Z; Sur S; Soldan A; Pettigrew C; Miller M; Oishi K; Bilgel M; Moghekar A; Pillai JJ; Albert M; Lu H
    Radiology; 2019 Jul; 292(1):140-148. PubMed ID: 31012816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels.
    Steward A; Biel D; Dewenter A; Roemer S; Wagner F; Dehsarvi A; Rathore S; Otero Svaldi D; Higgins I; Brendel M; Dichgans M; Shcherbinin S; Ewers M; Franzmeier N
    JAMA Neurol; 2023 Dec; 80(12):1295-1306. PubMed ID: 37930695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensities are associated with amyloid burden in APOE4 non-carriers.
    Noh Y; Seo SW; Jeon S; Lee JM; Kim JH; Kim GH; Cho H; Yoon CW; Kim HJ; Ye BS; Kim ST; Choe YS; Lee KH; Kim JS; Ewers M; Weiner MW; Lee JH; Werring DJ; Kang DR; Kim CS; Na DL
    J Alzheimers Dis; 2014; 40(4):877-86. PubMed ID: 24577457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.
    Head D; Bugg JM; Goate AM; Fagan AM; Mintun MA; Benzinger T; Holtzman DM; Morris JC
    Arch Neurol; 2012 May; 69(5):636-43. PubMed ID: 22232206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal changes in
    Luckett ES; Schaeverbeke J; De Meyer S; Adamczuk K; Van Laere K; Dupont P; Vandenberghe R
    Neuroimage Clin; 2023; 37():103321. PubMed ID: 36621019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep, 24-Hour Activity Rhythms, and Subsequent Amyloid-β Pathology.
    Nguyen Ho PT; Hoepel SJW; Rodriguez-Ayllon M; Luik AI; Vernooij MW; Neitzel J
    JAMA Neurol; 2024 Aug; 81(8):824-834. PubMed ID: 38913396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.
    Belloy ME; Napolioni V; Han SS; Le Guen Y; Greicius MD;
    JAMA Neurol; 2020 Jul; 77(7):849-862. PubMed ID: 32282020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
    Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O
    Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between APOE4 allele and regional amyloid and tau burdens in cognitively normal older individuals.
    Hong YJ; Kim CM; Lee JH; Sepulcre J
    Sci Rep; 2022 Aug; 12(1):14307. PubMed ID: 35995824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E4 Moderates the Association Between Vascular Risk Factors and Brain Pathology.
    Kaufman CS; Morris JK; Vidoni ED; Burns JM; Billinger SA
    Alzheimer Dis Assoc Disord; 2021 Jul-Sep 01; 35(3):223-229. PubMed ID: 33734100
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Erickson CM; Schultz SA; Oh JM; Darst BF; Ma Y; Norton D; Betthauser T; Gallagher CL; Carlsson CM; Bendlin BB; Asthana S; Hermann BP; Sager MA; Blennow K; Zetterberg H; Engelman CD; Christian BT; Johnson SC; Dubal DB; Okonkwo OC
    Neurology; 2019 Apr; 92(16):e1878-e1889. PubMed ID: 30867273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease.
    Fleisher AS; Chen K; Liu X; Ayutyanont N; Roontiva A; Thiyyagura P; Protas H; Joshi AD; Sabbagh M; Sadowsky CH; Sperling RA; Clark CM; Mintun MA; Pontecorvo MJ; Coleman RE; Doraiswamy PM; Johnson KA; Carpenter AP; Skovronsky DM; Reiman EM
    Neurobiol Aging; 2013 Jan; 34(1):1-12. PubMed ID: 22633529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular response to exercise interacts with individual genotype and amyloid-beta deposition to influence response inhibition with aging.
    Palmer JA; Kaufman CS; Vidoni ED; Honea RA; Burns JM; Billinger SA
    Neurobiol Aging; 2022 Jun; 114():15-26. PubMed ID: 35344819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study.
    van Arendonk J; Neitzel J; Steketee RME; van Assema DME; Vrooman HA; Segbers M; Ikram MA; Vernooij MW
    Brain; 2023 Jan; 146(1):337-348. PubMed ID: 36374264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.
    Lehmann M; Ghosh PM; Madison C; Karydas A; Coppola G; O'Neil JP; Huang Y; Miller BL; Jagust WJ; Rabinovici GD
    J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):266-73. PubMed ID: 23965289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction Between BDNF Val66Met and APOE4 on Biomarkers of Alzheimer's Disease and Cognitive Decline.
    Stonnington CM; Velgos SN; Chen Y; Syed S; Huentelman M; Thiyyagura P; Lee W; Richholt R; Caselli RJ; Locke DEC; Lu B; Reiman EM; Su Y; Chen K
    J Alzheimers Dis; 2020; 78(2):721-734. PubMed ID: 33044176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.
    Toledo JB; Habes M; Sotiras A; Bjerke M; Fan Y; Weiner MW; Shaw LM; Davatzikos C; Trojanowski JQ;
    J Alzheimers Dis; 2019; 69(3):783-793. PubMed ID: 31127775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.